PhaseBio Pharmaceuticals, Inc. (PHAS): Price and Financial Metrics


PhaseBio Pharmaceuticals, Inc. (PHAS): $3.75

-0.23 (-5.78%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

PHAS Stock Price Chart Interactive Chart >

Price chart for PHAS

PHAS Price/Volume Stats

Current price $3.75 52-week high $5.83
Prev. close $3.98 52-week low $2.60
Day low $3.73 Volume 887,100
Day high $4.03 Avg. volume 513,366
50-day MA $3.27 Dividend yield N/A
200-day MA $3.62 Market Cap 170.41M

PhaseBio Pharmaceuticals, Inc. (PHAS) Company Bio


PhaseBio Pharmaceuticals, Inc. engages in the development and commercialization of biotherapeutics for the treatment of orphan diseases. It focuses on cardiopulmonary disorders. The company was founded by Ashutosh Chilkoti and Clay Bernardin Thorp in January 2002 and is headquartered in Malvern, PA.


PHAS Latest News Stream


Event/Time News Detail
Loading, please wait...

PHAS Latest Social Stream


Loading social stream, please wait...

View Full PHAS Social Stream

PHAS Price Returns

1-mo 13.98%
3-mo -0.79%
6-mo -1.32%
1-year -26.33%
3-year N/A
5-year N/A
YTD 11.61%
2020 -45.01%
2019 97.73%
2018 N/A
2017 N/A
2016 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.8082 seconds.